Description
Seeking people whose generalized Myasthenia Gravis (gMG) symptoms started within the past year for a study of an investigational biological drug.
Overview
Participants in this study will receive a weekly injection of the study drug. After 4 weeks of the injections during an office visit participants might be able to self administer the injection at home. There will be at least 33 study visits, although at least 13 could be done from home.
What we're hoping for
We are studying if an investigational biological drug quickly helps symptoms of new-onset generalized Myasthenia Gravis (gMG) and if it helps without the need for other treatments.
Additional Information
ClinicalTrials.gov Identifier: NCT06909214